Mechanical clot treatment device

Abstract
An embolism treatment device includes an elongated core wire having a coil tip coupled to the distal end of the core wire and a cage assembly substantially coaxial to the core wire, having a first deployment shape and a second expanded shape. The core wire is freely moveable axially through the cage assembly. The device additionally includes an inner coil surrounding the core wire within the cage assembly and an actuator element, having a first position and a second position, located proximally to the cage assembly, wherein when the actuator element is in the first position, the cage assembly is in the first deployment shape and when the actuator element is in the second position, the cage assembly is in the second expanded shape.
Description
FIELD OF THE INVENTION

This is a medical device used to treat embolic strokes. In particular, it is a surgical device usually delivered through an intravascular catheter. It may be used in several ways. It may, for instance, be used to open a clear passageway adjacent a thrombus to allow both blood and medication to bypass the clot. It may be used to pierce and to remove a thrombus. These thrombi are often found in tortuous vasculature. The device may include several sections: an elongated core element, a proximal cage assembly, a distal filter, and an actuator. The core element is at least a core wire. Placed around the distal end of the core element is a collapsible, but preferably self-expanding or self-collapsing, proximal cage assembly and a more distally located, preferably self-expanding or self-collapsing, distal filter, cage assembly, or other filter component. These components are preferably radio-opaque. The proximal end of the proximal cage is typically is affixed to an actuator in such a way as to allow expansion of the cage after deployment. The proximal cage assembly may be used for collecting emboli or for displacing them to allow blood flow to resume, either with or without concurrent clot-dissolving drug treatment. The distal sector, whether a cage or a fan, is placed distally of the thrombus to collect portions of the thrombus which may loosen during the treatment or removal procedure.


BACKGROUND OF THE INVENTION

This surgical device is designed to displace or to penetrate emboli found in the human vasculature. The device has several major components including a proximal (or displacing cage) and a distal filter. Depending upon the chosen procedure, the device is inserted so that the displacing or proximal cage is either towards the venous side of the clot or adjacent the clot. The proximal cage is expanded either to displace the clot away from the arterial wall and allow flow of fluid (e.g., blood and medications such as anti-thrombolytics or other lysing agents) past (or to) the formerly occluded site or to engage the clot for removal using the cage as a collector assembly, expand once past the target emboli, and catch or net the embolism (or a portion of the embolism) for removal from patient's blood vessels. In some situations, the device may be used to move the clot to another position in the vasculature; perhaps for recovery using another device or to canalize the clot for improved blood flow. The distal filter member is always placed distal to the thrombus to catch any portions which may break away.


Other devices to treat vascular emboli are known. The use of inflatable balloons to remove emboli has been practiced for many years. The “Fogarty catheter” has been used, typically in the periphery, to remove clots from arteries found in legs and in arms. These well known devices have been described in some detail in U.S. Pat. No. 3,435,826, to Fogarty and in U.S. Pat. Nos. 4,403,612 and 3,367,101. These patents describe a balloon catheter in which a balloon material is longitudinally stretched when deflated.


Emboli occasionally form around the valves of the heart and then are dislodged and follow the blood flow into the distal regions of the body. They are particularly dangerous if the emboli passes to the brain and causes an embolic stroke. As will be discussed below, many such occlusions lodge in the middle cerebral artery (MCA), although such is not the only site where emboli come to rest. Obviously, when blood flow is inhibited or cut off completely from a portion of the brain, the brain's oxygen supply is limited causing severe health problems.


In procedures for removing emboli using the Fogarty catheter or other similar catheters, it is typical, first, to locate the clot using fluoroscopy. The embolectomy catheter is then inserted and directed to the clot. The distal tip of the balloon catheter is then carefully moved through the center of the clot. Once the balloon has passed through the distal side of the clot, the balloon is inflated. The balloon catheter is then gradually and gently withdrawn. The balloon, in this way, acts to pull the clot ahead of the balloon. The majority of procedures using a Fogarty catheter repeat these steps until the pertinent vessel is cleared of clot material.


Such vaso-occlusions occur in a wide variety of sites within the body. The lodging of thrombus in various sites is often complicated by the presence of atherosclerosis. This disease causes the vessels to become tortuous and narrowed. These anomalies are often considered to be the result of the growth of atherosclerotic plaque. Clots occurring in these diseased vessels are difficult to remove using balloon or Fogarty catheters.


Removal of emboli using balloon catheters is rife with potential problems. One such problem occurs during removal of a clot. The resistance to such removal often causes the balloon portion of the catheter to evert over the tip of the catheter. Should the user need to partially deflate the balloon during such a deflation, the distal tip of the balloon may become distended and angulate. Another difficulty with balloon catheters is the possibility of damage to the intima of arteries. Inflation pressures can create forces significant enough to score such a vessel lining or dislodge plaque lodged on such a wall. In the worst case, the balloon may rupture leaving balloon portions in the bloodstream.


Movement of a balloon in the MCA using only a balloon can displace the clot through more proximal branches into other large vessels such as the internal carotid artery (ICA) and then into other vessels and may pressure the clot into branching vessels.


There are a variety of different devices intended for use in replacing balloon catheters and in using a device other than a balloon catheter in so removing the emboli.


One such device is shown in U.S. Pat. No. 4,030,503 to Clark III. This patent describes a spiral helix affixed to the distal end of a catheter. In particular, the spiral helix is designed to be rotated and pushed forward through the clot. It is said that the helix screws into the clot, and when it is firmly embedded or is past the clot, the catheter is pulled out of the vessel without rotation. The catheter is said to operate like a corkscrew.


A similar catheter is described in U.S. Pat. No. 4,706,671 to Weinrib. This catheter also has a coil section at its distal end. The coil section is said to be stretched initially into a generally linear insertion position for removing inwardly in a vessel. The coil member is then expanded into the form of a hollow conical scoop to then scoop clot material from the blood vessel. The coil member is stiffened by an internal wire which is then removed. The hollow passageway is then filled with a liquid to stiffen the coils. The coils are said to be of an elastomeric material.


U.S. Pat. No. 4,762,130 to Fogarty et al., describes a helical balloon attached to the distal end of a catheter. The helical or bellowed balloon is maintained in a generally linear condition and passed into a clot. Once the catheter balloon within the clot is inflated, the balloon and adjoining clot are removed together.


Another similar device used more to grip and shear atherosclerotic deposits rather than to remove thrombi is described in U.S. Pat. No. 4,890,611 to Monfort et al. This device incorporates a pair of helical wires placed on the distal end of a wire. The flexible wire is pulled against a flexible catheter and the two helically configured loops expand to form a shearing apparatus. The totality of the apparatus is then twisted by means of a handle so that the pair of helically wound loops cuts through and is said to retain sections of plaque for removal from the vessel.


Another thrombus extraction system is shown in U.S. Pat. No. 5,011,488, to Ginsberg. In using this device, an inflatable balloon having a proximal conic shape is deflated and passed through a thrombus. It is then expanded and retracted so that the proximal passage pulls the thrombus into contact with an aspirator. The aspirator then removes the clot or thrombotic material from the vessel.


An alternative configuration of the expandable member is also described in the Ginsberg patent mentioned just above. In this variation, a wire coil is attached to an extension wire which may be moved between an extended position and a retracted position. The retracted or expanded configuration is illustrated to have a conical shape. The cone is shown to be one which has a smaller end proximally.


U.S. Pat. No. 5,112,347, to Taheri, shows an inflatable balloon type embolectomy catheter. The balloon has a number of fingers arranged in a leaf spring arrangement inside the balloon. The balloon is hydraulically inflated and forms a cone after inflation. The deflated device is shown in FIGS. 11 through 14 to be passed distally past an embolism before inflation. After inflation, the large end of the balloon collects the embolism as it is pulled past the appropriate site in the vessel.


U.S. Pat. No. 5,192,286, to Phan, shows a retrieval catheter for removing materials from various body lumen. The retrieval catheter is shown to have a slack net which may be collapsed for passage into a lumen past the material to be collected. The net is unfolded and materials such as uretral stones are removed.


U.S. Pat. No. 5,411,509 to Hilal, shows an embolectomy catheter having an elastomeric foam tip attached distally. The foam tip has an actuator means suitable for forming the foam section both longitudinally and radially in response to activation of the actuation means. In practice, the catheter tip is pressed past an embolism, inflated, and retracted with the clot being pushed proximally as retraction occurs.


U.S. Pat. No. 5,490,859, to Mische et al., shows an intravascular occlusion material removal device having an expandable material removal element made up of a number of wires passing between the two ends of such element, a catheter shaft, a drive shaft for spinning the material movement element within the blood vessel, and a collection portion placed on the material removal element for collecting any occlusion material removed by the expandable material removal element. The drive shaft may be operated by a motor connected to the proximal end of the drive shaft.


None of these devices show the device described below.


SUMMARY OF THE INVENTION

This is a surgical device usually delivered through an intravascular catheter. It is designed variously to displace or to pierce and remove emboli particularly when found in tortuous vasculature.


This embolectomy device includes several sections. First, the device has a core element. The core element preferably has at least several major finctions: first, the distal portion may act as a guidewire for vessel navigation to the treatment site; second, the distal portion assists in puncturing the clot or displacing it away from the arterial wall; and third, it cooperates with the collection assembly during the deployment of that assembly. The core element may be a simple core wire (perhaps enhanced with an adherent braid) fixedly attached to the distal end of the cage assembly or a tubular member attached to the collection assembly having a removable core or guidewire in its interior passageway. Preferably, the core element is able to rotate freely with respect to collection assembly to preserve its abilities as a guidewire while preserving the cage assembly shape and integrity.


Placed distally on the core element are a pair of cage or filter elements. The proximal element preferably is an expandable and collapsible self expanding cage assembly. The proximal element may be self-expanding or self-collapsing. The distal element may also be a cage and design similar to the proximal element or of other filter design. The distal element is intended to catch any errant thrombus or clot fragments. Both elements may either be fixedly or rotatably joined to the core wire. Most preferred of the designs for the cage assembly involves a super-elastic alloy ribbon or wire braid wrapped with a platinum wire or otherwise made radio-opaque.


The assembly further may have an actuator which permits or causes the collector assembly to expand or to contract after deployment. The actuator may be mechanical in nature or electrolytic, or may include a balloon. When the actuator is mechanical, it is typically attached to the proximal end of the proximal cage assembly to allow or cause controllable expansion of the distal and proximal cage assemblies.


Another embolectomy device in accordance with an embodiment of the present invention includes an elongated core wire with a coil tip coupled to the distal end of the elongated core wire and a cage assembly substantially coaxial to the corewire, having a first deployment shape and a second expanded shape. The corewire is freely moveable axially through the cage assembly. The device further includes an inner coil surrounding the core wire within the cage assembly and an actuator element, having a first position and a second position, located proximally to the cage assembly, wherein when the actuator element is in the first position, the cage assembly is in the first deployment shape and when the actuator element is in the second position, the cage assembly is in the second expanded shape.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a generalized schematic of a portion of the arterial system of the head specifying in particular the position of an embolism in the middle cerebral artery.



FIGS. 2A and 2B show a side, partial cutaway and a side view of the distal end of one variation of the device respectively as expanded and as unexpanded.



FIGS. 3A and 3B show, respectively, a side, partial cutaway and an end view of another variation of the device.



FIGS. 4A, 4B, and 4C show, respectively, side views of various distal tips of the device.



FIG. 5A shows a close-up of braid section comprised of a wrapped wire. FIG. 5B shows a close-up of braid section comprised of a wrapped ribbon.



FIGS. 6A, 6B, 6C, and 6D show a generalized sequence of steps for use of the inventive device for displacing a thrombus for restoration of flow past the occluded site.





DESCRIPTION OF THE INVENTION

This device is a surgical implement. It is designed variously to move a thrombus aside and provide a fluid passageway along that thrombus or to penetrate and at least partially to retrieve emboli situated in human vasculature. It is intended to be used rapidly as a flow restoration device. Even in those instances where the embolism is not or cannot be completely removed, this inventive device is believed to be useful in displacing, extracting, or removing a portion of the clot and thereby permitting restoration of partial blood flow. It can be used to move the clot to a more advantageous site in the body. It is suitably flexible to be placed in the distal tortuous vasculature of the brain and hence is useful in treating blocking emboli found there. This device may be considered a partial treatment for embolic stroke, for instance, when used with the addition of thrombolytics.


As a matter of practical experience, a large proportion of emboli sloughed into the brain are seldom longer than about 1 to 2 centimeters and, for a variety of reasons both physiological and hemodynamic, settle in the middle cerebral artery (MCA). As is shown in FIG. 1, the path from the site of origin of a traveling embolus—often the heart—to the MCA is via the common carotid artery past the branch point forming the external and internal carotid arteries into the internal carotid artery (ICA). The MCA is generally considered to be the continuation and termination of the ICA after the siphon and after the branching sites of a variety of other arteries, e.g., the ophthalmic artery, the anterior communicating artery, the posterior communicating artery, and others. The etiology of such an occlusion is varied, varying, and complicated. The occlusion (100) is shown in the MCA in FIG. 1 at the noted site.


Treatments for such embolic occlusions include catheterization of the patient and introduction of tissue plasminogen activator (TPA) or urokinase or other clot lysing agents to the site of the occlusion. Additionally the embolic occlusion may be penetrated—often with a microcatheter—and the TPA or urokinase introduced distally of the occlusion. Removal of the catheter provides a modest passageway for resumed or increased blood flow past the then-partial occlusion.


This inventive device is for the rapid restoration of fluid or blood flow past the occlusion. We have found that it may be used in a variety of ways. For instance, when approaching the clot from the arterial end, the device can be used either to bypass the clot along the vessel wall and, upon expansion of the proximal cage assembly, to allow flow of blood across the occlusion using the interior of the proximal cage assembly as a fluid passageway.


Alternatively, the inventive device may be used to canalize or remove an occlusion, via the steps of penetrating the occlusion, expanding a cage assembly distally of the embolism, and preferably removing at least a part of the embolism along with the cage and its attendant catheter.


The distal cage or filter element is to catch and retain any thrombus fragments and prevent them from moving distally.



FIG. 2A is a diagrammatic portrayal of the major portions of a desired variation (200) of the device and provides a general convention for several of the terms used herein.


The assembly typically includes a core element, often a core wire (202), and optional coil tip (204) to provide a measure of radio-opacity to the distal tip and protect against damage to the intima, a distal cage assembly, filter, or element (206) which may be used as an embolism collector, and a proximal cage assembly or element (208). Because of the “fineness” of the device, the coil tip (204) may also serve the same function as a guidewire tip. The length of the coil tip (204) may be up to 4 or 5 centimeters in such instances. Further, and as is discussed below, the core element may be an assembly comprising a tubular member further containing a removable core or guidewire. In one highly desirable variation of the invention, a separation member (210) is used to separate distal cage or element (206) from the proximal cage (208). As will be explained in greater detail below, a preferred variation of the invention is one in which the distal member (206) and the proximal cage (208) are made of a single tubular member woven variously from wire or ribbon. The two cages are separated by a separation member (210) which, as seen in partial cross section in FIG. 2A, is a simple tubular member made from, e.g., an appropriate metal or polymer.


The distal cage assembly (206) and proximal cage assembly (208) are collapsible for passage along-side of or for penetration and passage through the embolism and are generally self expandable once in position. Other components and devices may, obviously, be used to expand the distal cage assembly (206) and proximal cage assembly (208), are discussed at some length below.


The distal cage assembly (206) and proximal cage assembly may either self-expand when the actuator element (212) is permitted to move from its introduction position to its deployment position or it may self-collapse. Self-collapsing may provide a measure of safety in the event that the device becomes inoperable. Withdrawal of a collapsed device is simpler than is removal of an expanded device. The actuator element (212) is operable by the person.



FIG. 2B shows the shape of the variation shown in FIG. 2B in the form in which it is introduced. Actuator (212) (not shown) has been pulled proximally against the core wire (202) (not shown in FIG. 2B). As will be shown below, this slim or first configuration passes through an appropriately sized delivery catheter and may be pushed by or through a clot prior to expansion to the deployed or second configuration shown in FIG. 2A.


The distal cage assembly (206) and proximal cage assembly (208) are preferably made of a super-elastic alloy wire or ribbon. Some stainless steels are suitable but the ready availability of nickel-titanium alloys in a wide variety of shapes and sizes makes this choice an easy one. In particular, we have found that ribbons as thin as 0.75 mils in thickness and as narrow as 2 mils in width are suitable for this device. Thicker and wider ribbons are also suitable in some instances as the situation requires. Preferred ribbons are between 0.75 and 1.5 mils in thickness and 3 and 7 mils in width. Most preferred are 0.8 mils and 4 mils respectively.


By “wires” we mean to include filamentary shapes having cross-sections where the thickness/width ratio is greater than 0.5 to and including 1.0. The cross-sectional form may be circular, square, oval, etc.


At least a minority of the ribbons may be a suitable stainless steel (e.g., 304SS, 306SS, etc.) or other such alloy. A desirable variant is the substitution of one or more ribbons of the braid (or the addition of one or more ribbons) with a radio-opaque material such as platinum. This obviously permits the user to visualize the position of the distal cage assembly (206) and proximal cage assembly (208) during a procedure.


A technical basis for the term “super-elastic” is found in the class of nickel-titanium alloys known as “nitinol”—alloys discovered by the United States Naval Ordnance Laboratory. These materials are discussed at length in U.S. Pat. Nos. 3,174,851 to Buehler et al., 3,351,463 to Rozner et al., and 3,753,700 to Harrison et al. Alloys especially suitable for this invention are those containing at least 1.5% (wt.) and up to about 8% (wt.) or more, of one or more alloying members selected from the group consisting of vanadium, chromium, manganese, iron, and cobalt. By the term “ribbon”, we intend to include elongated shapes, the cross section of which are not square or round and may typically be rectangular, oval, or semi-oval. They should have an aspect ratio of 0.5 (thickness/width) or less.


The distal cage (206) and proximal cage (208) may be made by winding a ribbon or a wire onto a mandrel having an exterior form to produce the relaxed shape found in FIG. 2A. The mandrel and wound ribbon are preferably heated for a suitable period of time (e.g., 750° to 1200° F. for one-half to two hours) to produce an assembly which has the portrayed shape. For use in the MCA, the outer diameter of the device after deployment need not be any larger than about 3 mm. It is desirable that the collapsed or non-deployed device have a diameter no larger than about 1 mm. The expansion ratio between any of the deployed and deployable devices discussed herein typically need not be any more than about 3:1 to be effective in the MCA. Expansion ratios between 2:1 and 10:1 are appropriate in this invention. These ratios are suitable for each variation of the invention. The invention is not so limited, however.


In some designs of the device, it is permissible to use an actuator as an active deployment element rather than as a mere restraint on the premature expansion of the cage assembly. Examples of such actuators are shown in U.S. patent application Ser. Nos. 08/686,304, 08/701,155, and 08/869,346 assigned to Target Therapeutics and all of which are incorporated by reference.



FIGS. 3A and 3B show a cross-section of another variation of the inventive device related to that variation found in FIGS. 3A and 3B but employing a slightly more complicated distal cage or filter assembly.



FIGS. 3A and 3B show respectively a partial cross-section of a further variation (220) of the invention shown, as above, a device having a central core wire (222) and a proximal cage assembly (224). Proximal cage assembly (224) is shown to be a woven braid of ribbons, preferably of a superelastic alloy, but as with variations in this Application, may be made of wires as that term is defined herein. It is to be seen from FIG. 3A that the shape of the proximal cage assembly (224) is somewhat more columnar than that shown in FIG. 2A. This shape is a preferred one because of its ease of manufacture. It may be produced in such a way that it is of significant length for use in long emboli. Actuator tubular member (226) is also shown in this variation, as is separator element (228). A major difference from the variation (200) shown in FIGS. 2A and 2B is the structure of the distal filter assembly (230). Although the structure of distal filter assembly (230) is not critical to the concepts of this invention in that it may be of any desirable shape capable of catching small bits of emboli sloughed from the embolus against which a proximal cage assembly (224) is pressing, the depicted distal filter assembly (230) is exempletive of the shape of assemblies suitable for placement on this section of the overall assembly. In this variation, a plurality of petal-shaped wires (232) which may or may not overlap when deployed, are seen. Optional spacer wires (234) are seen as supporting assembly tip member (236) to provide the distal end of core wire (238) with a measure of radial placement.



FIGS. 3A and 3B show the distal assembly in its deployed configuration. Because of the distal rake of filter members (232), those filter members (232) may be easily retracted into a catheter lumen when one desires to remove this device from the human body.



FIGS. 4A, 4B, and 4C show various distal treatments of the overall device. As has been noted above, the core wire may be fixed within the cage members, it may be provided with limited movement axially within the cage members, or it may be provided with full axial movement in which case the core wire acts and may be used as a guidewire for the device.



FIG. 4A shows a very simple variation of the invention in which a core wire (242) is fixably attached to a distal coil (244). The distal coil (244) also serves as an anchoring means for the distal cage assembly (246). This variation of the invention is simple and inexpensive and is suitably useful particularly when the device need not be extended too far into tortuous vasculature.



FIG. 4B shows another variation of the invention also having a woven braided ribbon distal cage (248). However, unlike the variation shown in FIG. 4A, this variation utilizes a core wire (250) which is freely moveable axially through the center of that distal cage (248). The distal cage (248) has a tubular liner (252) which moves independently of the actuator (shown in FIGS. 2A and 3A above). Core wire (250) does act as a guidewire and may be used to provide a pathway through tortuous vasculature for the device to follow. Liner (252) is preferably made of a material such as polytetrafluoroethylene (e.g., Teflon) and desirably extends all the way to the proximal end of the catheter and acts as an actuator for the cages. A desirable variation of this invention includes the securing of distal cage assembly (248) by use of a tubular member of, e.g., a thermoplastic, which fixes the distal-most end of distal cage assembly (248) to inner liner (252). A radio-opaque marker (256) (which is optional in this variation for reasons which will be explained below) is also depicted.



FIG. 4C shows a further variation (258) of this invention in which core wire (260) is rotatable with respect to distal cage (262) but has limited axial movement therein. This obviously allows the user to position the bent coil tip (244) in a position to select or sub-select from turns or Y's in the tortuous vasculature without twisting the whole device (258). Limitation of the movement of the core wire (260) within the device (258) is accomplished via the use of bushing (264) placed distally in the distal cage assembly (262). The inner diameter of bushing (264) will not allow coil (244) to pass proximally nor will it allow coil (266) to pass distally. Coil (266) may be used as a marker coil if so desired. Bushing (264) also desirably forms a joint with outer tubular member (286) to firmly place the distal-most end of distal cage assembly (262).


An independent feature shown in FIG. 4C is the presence of a braid member (268) which is adherent to core wire (260). Braid member (268) is for the specific purpose of providing kink resistance and improved torqueability. The material used as a braid on the core wire (260) may be any of a different number of materials. Highly desirable, though, is the use of a braid of super-elastic alloy. Certain classes of these materials have been discussed in detail above. The braid material (268) may be stainless steel wire or polymeric filament. In some variations, materials known as Liquid Crystal Polymers (LCP's) may be employed simply because they have extremely high tensile strength and do not easily stretch. This braid allows the overall diameter of the core wire assembly—the core wire (260) and the braid (268)—to be smaller than a core wire having appreciably the same performance. These more complex designs may be useful in situations in which extremely small vasculature must be penetrated to treat the errant thrombus.


As noted elsewhere, the location of the cage assembly should be visible using fluoroscopy. Various methods have been suggested above. One highly preferred method is shown in FIGS. 5A and 5B. In essence, at least some of the elements (ribbons or wires) making up the cage assemblies are provided with significant radio-visibility via the placement of a radio-opaque covering on these elements. A metallic coating of a metal having comparatively more visibility, during fluoroscopic use, than stainless steel is preferred. Such metals are well-known but include gold and members of the Platinum Group of the Periodic Table, e.g., platinum, palladium, rhenium, rhodium, etc. The cage assembly wires or ribbons may be electroplated or otherwise provided with a continuous coating but a thick coating may be had by wrapping the element with a radio-opaque wire or ribbon.


Another material suitable for such a service is a structural material filled with a radio-opaque material. For instance, a suitably fine tubing of, e.g., nitinol or stainless steel, filled with platinum or gold is commercially available. Fort Wayne Metals of Fort Wayne, Ind. sells such a product as a “drawn filled tube.”



FIG. 5A shows a portion of a cage assembly (300) made up of a woven braid of wires (302) which in turn are tightly wrapped with radio-opaque wires (304). The right side of FIG. 5A is a partial cut away showing the wires (302) and the radio-opaque wires (304) in cross-section.


As an example of the device shown in FIG. 5A, we have found that nickel/titanium super-elastic alloy wire having a diameter in the range of 0.001″ to 0.004″ wrapped with 0.0001″ to 0.002″ diameter platinum wire is suitable and is quite visible.



FIG. 5B shows a partial cut-away of a cage assembly (308) constructed of ribbon (310) as described above and further wrapped with radio-opaque wires (312). As was the case with the FIG. 5A variation, the right side of the drawing is a partial cut away showing the internal ribbon (310).


The variations of the cage assemblies shown in FIGS. 5A and 5B may be used in place of any of the cage assemblies found elsewhere herein.



FIGS. 6A to 6D, show in generic fashion, one method of using the device described herein.



FIG. 6A schematically depicts an artery (400) containing a blocking clot (402). Blood flow through artery (400) is severely compromised. A variation of the inventive device (404) similar to that shown in FIGS. 2A and 2B is shown in the artery (400) in FIG. 6B. This variation (404) has a rotatable core wire (406) which is useful as a guidewire. It has a distal woven braided cage assembly (408), a proximal braided cage assembly (410) and a tubular actuator (420). Also shown is the delivery catheter (412) having orifices (414) for perfusion of appropriate medicines.


Many clots such as clot (402) will push the core wire (406) tip aside as the guidewire contacts the clot. Indeed, in most instances, such is preferred. The core wire (406) then slips along the wall of the artery (400) as the device (404) is advanced.



FIG. 6C shows an appropriate placement of the distal cage assembly (408) past the occlusion (402) and of the proximal cage assembly (410) adjacent to the clot prior to deployment. The proximal cage assembly (410) length assembly is desirably selected so that it overlaps both ends of clot (402).


Upon expansion of the cage assemblies (408, 410) to their expanded shape, blood will flow from the arterial to venous end of the clot (402) through the lumen of the open proximal cage assembly (410). Desirably, distal cage assembly (408) has an expanded diameter which approximates the size of the artery (400) lumen. The distal filter assembly (408) is there solely to prevent distal movement of the clot (402) or fragments of the clot. Thrombolytics may be introduced through the orifices (416) to dissolve clot (402). It is highly desirable that the proximal cage assembly (410) be used to restrain the clot (402) from movement in the vessel (400) so that the thrombolytics may completely dissolve the clot (402) while so restrained. This procedure obviously provides a continuing source of thrombolytics to the clot (402) and further provides a large clot surface area upon which the thrombolytics may work.


Alternatively, or in addition to the steps outlined above, clot (402) can be retained or retrieved by the expanded distal cage assembly (408) and removed to another site along with the distal cage assembly (408) and catheter (412).


It should be apparent that the cage assembly of this invention may be re-collapsed and re-deployed as necessary to displace or collect emboli as necessary or desired.


The design of such variations is routine and is within the skill of an ordinary designer in this art. Similarly, obvious variants of the invention described above are within the scope of the invention. This and other known or non-critical items have been omitted from the drawings for the sake of brevity and clarity of the invention disclosed here.

Claims
  • 1. An embolism treatment device comprising: an elongated core wire having a distal end and a proximal end;a cage assembly including a proximal cage connected to a distal cage, the cage assembly having a distal end, a proximal end, a first deployment shape wherein both the proximal cage and the distal cage are in a deployment configuration, and a second expanded shape wherein both the proximal cage and the distal cage are in an expanded configuration, wherein the second expanded shape is different from the first deployment shape and wherein the cage assembly is substantially coaxial to the elongated core wire;a tubular member coupled to the distal end of the cage assembly, wherein the tubular member surrounds a distal portion of the core wire; andan actuator element, having a first position and a second position, located proximally to the cage assembly and substantially coaxial about the core wire, wherein when the actuator element is in the first position, the cage assembly is in the first deployment shape and when the actuator element is in the second position, the cage assembly is in the second expanded shape;wherein the core wire is freely moveable axially through the cage assembly;wherein the proximal cage and the distal cage are separated by a separation member.
  • 2. The embolism treatment device in claim 1, wherein the tubular member is a bushing.
  • 3. The embolism treatment device in claim 1, wherein the tubular member is a thermoplastic.
  • 4. The embolism treatment device in claim 1, further comprising an inner coil surrounding the elongated core wire within the cage assembly.
  • 5. The embolism treatment device in claim 4, wherein the inner coil is a marker coil.
  • 6. The embolism treatment device of claim 1, wherein the distal cage includes a plurality of petal shaped wires.
  • 7. The embolism treatment device of claim 6, wherein the plurality of petal shaped wires has a distal rake.
  • 8. An embolism treatment device comprising: an elongated core wire having a distal end and a proximal end;a cage assembly including a proximal cage connected to a distal cage, the cage assembly having a distal end, a proximal end, a first deployment shape, and a second expanded shape wherein both the proximal cage and the distal cage are in an expanded configuration, wherein the second expanded shape is different from the first deployment shape and wherein the cage assembly is substantially coaxial to the elongated core wire;an inner coil surrounding the core wire within the cage assembly; andan actuator element, having a first position and a second position, located proximally to the cage assembly and substantially coaxial about the core wire, wherein when the actuator element is in the first position, the cage assembly is in the first deployment shape and when the actuator element is in the second position, the cage assembly is in the second expanded shape;wherein the proximal cage and the distal care are separated by a separation member.
  • 9. The embolism treatment device in claim 8, wherein the inner coil is a marker coil.
  • 10. The embolism treatment device in claim 8, wherein the inner coil is prevented from passing distally on the core wire.
  • 11. The embolism treatment device in claim 8, further comprising a tubular member coupled to the distal end of the cage assembly and surrounding the core wire.
  • 12. The embolism treatment device in claim 11, wherein the tubular member is firmly placed on the core wire.
  • 13. The embolism treatment device in claim 8, wherein the core wire is freely moveable axially through the cage assembly.
  • 14. The embolism treatment device of claim 8, wherein the distal cage includes a plurality of petal shaped wires.
  • 15. The embolism treatment device of claim 14, wherein the plurality of petal shaped wires has a distal rake.
CROSS REFERENCE TO RELATED PATENT APPLICATION

This application is a continuation of U.S. application Ser. No. 09/452,528, filed on Dec. 1, 1999, now U.S. Pat. No. 6,383,205, which is a continuation of U.S. application Ser. No. 08/941,514, filed on Sep. 30, 1997, now U.S. Pat. No. 6,066,149.

US Referenced Citations (268)
Number Name Date Kind
3174851 Buehler, at al. Mar 1965 A
3351463 Rozner et al. Nov 1967 A
3367101 Garner et al. Feb 1968 A
3435826 Fogarty Apr 1969 A
3472230 Fogarty Oct 1969 A
3592186 Oster Jul 1971 A
3683904 Forster Aug 1972 A
3753700 Harrison et al. Aug 1973 A
3889657 Baumgarten Jun 1975 A
3952747 Kimmell, Jr. Apr 1976 A
3996938 Clark, III Dec 1976 A
4030503 Clark, III Jun 1977 A
4046150 Schwartz et al. Sep 1977 A
4295464 Shihata Oct 1981 A
4403612 Fogarty Sep 1983 A
4425908 Simon Jan 1984 A
4447227 Kotsanis May 1984 A
4561439 Bishop et al. Dec 1985 A
4580568 Gianturco Apr 1986 A
4590938 Segura et al. May 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4631052 Kensey Dec 1986 A
4643184 Mobin-Uddin Feb 1987 A
4650466 Luther Mar 1987 A
4662885 DiPisa, Jr. May 1987 A
4692139 Stiles Sep 1987 A
4705517 DiPisa, Jr. Nov 1987 A
4706671 Weinrib Nov 1987 A
4719924 Crittenden et al. Jan 1988 A
4723549 Wholey et al. Feb 1988 A
4728319 Masch Mar 1988 A
4733665 Palmaz Mar 1988 A
4762130 Fogarty et al. Aug 1988 A
4790812 Hawkins, Jr. et al. Dec 1988 A
4790813 Kensey Dec 1988 A
4794928 Kletschka Jan 1989 A
4794931 Yock Jan 1989 A
4800882 Gianturco Jan 1989 A
4807626 McGirr Feb 1989 A
4842579 Shiber Jun 1989 A
4857045 Rydell Aug 1989 A
4857046 Stevens et al. Aug 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4873978 Ginsburg Oct 1989 A
4885003 Hillstead Dec 1989 A
4886061 Fischelle et al. Dec 1989 A
4890611 Monfort et al. Jan 1990 A
4898575 Fischell et al. Feb 1990 A
4904431 O'Maleki Feb 1990 A
4907336 Gianturco Mar 1990 A
4921478 Solano et al. May 1990 A
4921484 Hillstead May 1990 A
4926858 Gifford, III et al. May 1990 A
4950277 Farr Aug 1990 A
4955895 Sugiyama et al. Sep 1990 A
4957482 Shiber Sep 1990 A
4969891 Gewertz Nov 1990 A
4979951 Simpson Dec 1990 A
4986807 Farr Jan 1991 A
4997435 Demeter Mar 1991 A
4998539 Delsanti Mar 1991 A
5002560 Machold et al. Mar 1991 A
RE33569 Gifford, III et al. Apr 1991 E
5007896 Shiber Apr 1991 A
5007917 Evans Apr 1991 A
5011488 Ginsburg Apr 1991 A
5019088 Farr May 1991 A
5034001 Garrison et al. Jul 1991 A
5041126 Gianturco Aug 1991 A
5053008 Bajaj Oct 1991 A
5053044 Mueller et al. Oct 1991 A
5071407 Termin et al. Dec 1991 A
5071425 Gifford, III et al. Dec 1991 A
5085662 Willard Feb 1992 A
5087265 Summers Feb 1992 A
5100423 Fearnot Mar 1992 A
5100424 Jang et al. Mar 1992 A
5100425 Fischell et al. Mar 1992 A
5102415 Guenther et al. Apr 1992 A
5104399 Lazarus Apr 1992 A
5108419 Reger et al. Apr 1992 A
5112347 Taheri May 1992 A
5122136 Guglielmi et al. Jun 1992 A
5133733 Rasmussen et al. Jul 1992 A
5135531 Shiber Aug 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5152777 Goldberg et al. Oct 1992 A
5160342 Reger et al. Nov 1992 A
5171233 Amplatz et al. Dec 1992 A
5180368 Garrison Jan 1993 A
5190546 Jervis Mar 1993 A
5192286 Phan et al. Mar 1993 A
5195955 Don Michael Mar 1993 A
5224953 Morgentaler Jul 1993 A
5306286 Stack et al. Apr 1994 A
5308354 Zacca et al. May 1994 A
5314444 Gianturco May 1994 A
5314472 Fontaine May 1994 A
5318576 Plassche, Jr. et al. Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5330484 Gunther et al. Jul 1994 A
5330500 Song Jul 1994 A
5350398 Pavcnik et al. Sep 1994 A
5354295 Guglielmi et al. Oct 1994 A
5354310 Garnic et al. Oct 1994 A
5356423 Tihon et al. Oct 1994 A
5366464 Belknap Nov 1994 A
5366473 Winston et al. Nov 1994 A
5370657 Irie Dec 1994 A
5370683 Fontaine Dec 1994 A
5376100 Lefebvre Dec 1994 A
5383887 Nadal Jan 1995 A
5383892 Cardon et al. Jan 1995 A
5383926 Lock et al. Jan 1995 A
5387235 Chuter Feb 1995 A
5395311 Andrews Mar 1995 A
5395349 Quiachon et al. Mar 1995 A
5397345 Lazerus Mar 1995 A
5405377 Cragg Apr 1995 A
5409454 Fischell et al. Apr 1995 A
5411509 Hilal May 1995 A
5415630 Gory et al. May 1995 A
5419774 Willard et al. May 1995 A
5421832 Lefebvre Jun 1995 A
5423742 Theron Jun 1995 A
5423829 Pham et al. Jun 1995 A
5423885 Williams Jun 1995 A
5425765 Tiefenbrun et al. Jun 1995 A
5443498 Fontaine Aug 1995 A
5449372 Schmaltz et al. Sep 1995 A
4842579 Shiber Oct 1995 A
5454795 Samson Oct 1995 A
5456667 Ham et al. Oct 1995 A
5462529 Simpson et al. Oct 1995 A
5476104 Sheahon Dec 1995 A
5484418 Quiachon et al. Jan 1996 A
5490859 Mische et al. Feb 1996 A
5507767 Maeda et al. Apr 1996 A
5512044 Duer Apr 1996 A
5527326 Hermann et al. Jun 1996 A
5527354 Fontaine et al. Jun 1996 A
5536242 Willard et al. Jul 1996 A
5540707 Ressemann et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5562724 Vowerk et al. Oct 1996 A
5569274 Rapacki et al. Oct 1996 A
5569275 Kotula et al. Oct 1996 A
5628761 Rizik May 1997 A
5634897 Dance et al. Jun 1997 A
5643297 Nordgren et al. Jul 1997 A
5643298 Nordgren et al. Jul 1997 A
5658296 Bates et al. Aug 1997 A
5662671 Barbut et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5695469 Segal Dec 1997 A
5695519 Summers et al. Dec 1997 A
5709704 Nott et al. Jan 1998 A
5720764 Naderlinger Feb 1998 A
5728066 Daneshvar Mar 1998 A
5728123 Lemelson et al. Mar 1998 A
5728129 Summers Mar 1998 A
5746758 Nordgren et al. May 1998 A
5749848 Jang et al. May 1998 A
5769816 Barbut et al. Jun 1998 A
5769871 Mers Kelly et al. Jun 1998 A
5779716 Cano et al. Jul 1998 A
5779722 Shturman et al. Jul 1998 A
5792157 Mische et al. Aug 1998 A
5792300 Inderbitzen et al. Aug 1998 A
5795322 Boudewijn Aug 1998 A
5797952 Klein Aug 1998 A
5800457 Gelbfish Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5807398 Shaknovich Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5817102 Johnson et al. Oct 1998 A
5827324 Cassell et al. Oct 1998 A
5833644 Zadno-Azizi et al. Nov 1998 A
5833650 Imran Nov 1998 A
5836868 Ressemann et al. Nov 1998 A
5843103 Wulfman Dec 1998 A
5846260 Maahs Dec 1998 A
5848964 Samuels Dec 1998 A
5855565 Bar-Cohen et al. Jan 1999 A
5876367 Kaganov et al. Mar 1999 A
5893867 Bagaoisan et al. Apr 1999 A
5895398 Wensel et al. Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5902263 Patterson et al. May 1999 A
5906618 Larson, III May 1999 A
5908435 Samuels Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5916193 Stevens et al. Jun 1999 A
5925016 Chornenky et al. Jul 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5925063 Khosravi Jul 1999 A
5928203 Davey et al. Jul 1999 A
5928218 Gelbfish Jul 1999 A
5934284 Plaia et al. Aug 1999 A
5935139 Bates Aug 1999 A
5938645 Gordon Aug 1999 A
5941869 Patterson et al. Aug 1999 A
5941896 Kerr Aug 1999 A
5947995 Samuels Sep 1999 A
5951585 Cathcart et al. Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5972019 Engelson et al. Oct 1999 A
5976172 Homsma et al. Nov 1999 A
5980555 Barbut et al. Nov 1999 A
5989210 Morris et al. Nov 1999 A
5989271 Bonnette et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
5997557 Barbut et al. Dec 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013085 Howard Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6042598 Tsugita et al. Mar 2000 A
6051014 Jang Apr 2000 A
6051015 Maahs Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059814 Ladd May 2000 A
6066149 Samson et al. May 2000 A
6066158 Engelson et al. May 2000 A
6068645 Tu May 2000 A
6086605 Barbut et al. Jul 2000 A
6096053 Bates Aug 2000 A
6117154 Barbut et al. Sep 2000 A
6129739 Khosravi Oct 2000 A
6136016 Barbut et al. Oct 2000 A
6142987 Tsugita Nov 2000 A
6152946 Broome et al. Nov 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6171328 Addis Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6203561 Ramee et al. Mar 2001 B1
6206868 Parodi Mar 2001 B1
6214026 Lepak et al. Apr 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6224620 Maahs May 2001 B1
6231544 Tsugita et al. May 2001 B1
6235044 Root et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6238412 Dubrul et al. May 2001 B1
6245087 Addis Jun 2001 B1
6245088 Lowery Jun 2001 B1
6245089 Daniel et al. Jun 2001 B1
6258115 Dubrul Jul 2001 B1
6264663 Cano Jul 2001 B1
6264672 Fisher Jul 2001 B1
6270513 Tsugita et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6277139 Levinson et al. Aug 2001 B1
6280413 Clark et al. Aug 2001 B1
6287321 Jang Sep 2001 B1
6290710 Cryer et al. Sep 2001 B1
6309399 Barbut et al. Oct 2001 B1
6319268 Ambrisco et al. Nov 2001 B1
6344049 Levinson et al. Feb 2002 B1
Foreign Referenced Citations (82)
Number Date Country
2000621 Apr 1990 CA
28 21 048 Jul 1980 DE
34 17 738 Nov 1985 DE
40 30 998 Oct 1990 DE
0 200 688 Nov 1986 EP
0 293 605 Dec 1988 EP
0 411 118 Feb 1991 EP
0 418 677 Mar 1991 EP
0 419 154 Mar 1991 EP
0 427 429 May 1991 EP
0 437 121 Jul 1991 EP
0 472 334 Feb 1992 EP
0 472 368 Feb 1992 EP
0 472 368 Feb 1992 EP
0 531 822 Mar 1993 EP
0 533 511 Mar 1993 EP
0 655 228 Nov 1994 EP
0 686 379 Jun 1995 EP
0 696 447 Feb 1996 EP
0 737 450 Oct 1996 EP
0 737 450 Oct 1996 EP
0 743 046 Nov 1996 EP
0 759 287 Feb 1997 EP
0 771 549 May 1997 EP
0 784 988 Jul 1997 EP
0 852 132 Jul 1998 EP
0 117 940 Sep 1998 EP
2 580 504 Oct 1986 FR
2 643 250 Aug 1990 FR
2 666 980 Mar 1992 FR
2 768 326 Mar 1999 FR
2 020 557 Nov 1979 GB
2 020 557 Jan 1983 GB
8-187294 Jul 1996 JP
764684 Sep 1980 SU
WO 8809683 Dec 1988 WO
WO 9203097 Mar 1992 WO
WO 9414389 Jul 1994 WO
WO 9424946 Nov 1994 WO
WO 9535066 Dec 1995 WO
WO 9601591 Jan 1996 WO
WO 9604875 Feb 1996 WO
WO 9610375 Apr 1996 WO
WO 9619941 Jul 1996 WO
WO 9623441 Aug 1996 WO
WO 9633677 Oct 1996 WO
WO 9717100 May 1997 WO
WO 9727808 Aug 1997 WO
WO 9742878 Nov 1997 WO
WO 9742879 Nov 1997 WO
WO 9802084 Jan 1998 WO
WO 9802112 Jan 1998 WO
WO 9823322 Jun 1998 WO
WO 9833443 Aug 1998 WO
WO 9834673 Aug 1998 WO
WO 9836786 Aug 1998 WO
WO 9838920 Sep 1998 WO
WO 9838929 Sep 1998 WO
WO 9839046 Sep 1998 WO
WO 9839053 Sep 1998 WO
WO 9846297 Oct 1998 WO
WO 9847447 Oct 1998 WO
WO 9849952 Nov 1998 WO
WO 9850103 Nov 1998 WO
WO 9851237 Nov 1998 WO
WO 9855175 Dec 1998 WO
WO 9909895 Mar 1999 WO
WO 9922673 May 1999 WO
WO 9923976 May 1999 WO
WO 9925252 May 1999 WO
WO 9930766 Jun 1999 WO
0 934 729 Aug 1999 WO
WO 9940964 Aug 1999 WO
WO 9942059 Aug 1999 WO
WO 9944510 Sep 1999 WO
WO 9944542 Sep 1999 WO
WO 9955236 Nov 1999 WO
WO 9958068 Nov 1999 WO
WO 0007655 Feb 2000 WO
WO 0009054 Feb 2000 WO
WO 0016705 Mar 2000 WO
WO 0049970 Aug 2000 WO
Related Publications (1)
Number Date Country
20020082558 A1 Jun 2002 US
Continuations (2)
Number Date Country
Parent 09452528 Dec 1999 US
Child 10082492 US
Parent 08941514 Sep 1997 US
Child 09452528 US